With the BeVigilant™ RAPID Platform, clinicians can get a simple and accurate† assessment to aid in the early detection of oral cancer potentially before lesions are visible. The BeVigilant RAPID Platform provides a qualitative result at the point–of–care, reporting a low, moderate or elevated levels of oral cancer biomarkers.